One thing I have noticed with all the bio's that I've played over the years. First this is a very unique company as INNV is actually making money and beating their own projections. The O/S is not a crazy billion shares as most stinky bio's have. This seems to be the real deal at this point.
My observation in the trading action is that most BS pinksheet bio companies run up right before the obvious FDA's rejection. For all the FDA approvals I have witnessed, the prices were either going down or in a quiet phase (sideways) when approval hit. The way this is trading I have a gut feeling we could see approval any day now, not next quarter or next year. The company did mention revised Q3 or Q4 so it can be tomorrow for all we know. The news today re-assures me that approval is very realistic and that approval is if not already know by a selected few.
Once/IF FDA approval come in, this will shoot up a few 100% before the bell. Company news seems to be at 6am in the morning so there will be hand over fist buying in the premarket. Shorts and the flippers have really better be careful right now, they are just days away from losing their shirts and the flippers crying in regret. As for the longs keep holding strong, the warrants will keep this stock above .25. Longs can only lose 100%, the shorts can lose infinite amount of money. The court is in the longs side right now.
GLTA!!!
